Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial

Liam S. Acheson,Nadine Ezard,Nicholas Lintzeris,Adrian Dunlop,Jonathan Brett,Craig Rodgers,Anthony Gill,Michael Christmass,Rebecca McKetin,Michael Farrell,Steve Shoptaw,Krista J. Siefried

Drug and Alcohol Dependence（2022）

引用 1|浏览7

暂无评分

摘要

•There is no approved pharmacotherapy option for methamphetamine withdrawal.•This is the first clinical trial of lisdexamfetamine for methamphetamine withdrawal.•Lisdexamfetamine is safe and feasible for treating acute withdrawal.•Participants found this treatment highly acceptable.•More work is needed to determine the efficacy of this treatment.

查看译文

关键词

Methamphetamine,Lisdexamfetamine,Withdrawal,Safety,Clinical trial,Pharmacotherapy,Treatment,Stimulant

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要